Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Brewers Use CRISPR to Make Hopless Beer

By Kenny Walter | March 21, 2018

New technology could enable your favorite India Pale Ale or American Amber Ale to be as hoppy as ever—without being brewed with actual hops.

Biologists from the University of California Berkeley have developed a way to create the flavors and aromas of hoppy beers without hops, by producing strains of brewer’s yeast with the gene editing technology CRISPR-Cas9 that both ferments the beer and provides two of the prominent flavor notes provided by hops.

To achieve this, the researchers inserted four new genes, as well as the promoters that regulate the genes, into industrial brewer’s yeast using the gene editing tools. Linalool synthase and geraniol synthase—two of the genes used that came from mint and basil—code for enzymes that produce flavor components common to several plants.

Genes from other plants that were reported to have linalool synthase activity—including olive and strawberry—were more challenging to work with.

Two other genes from yeast boosted the production of precursor molecules required to make linalool and geraniol—the hoppy flavor components.

All the genetic components—the Cas9 gene, four yeast, mint and basil genes and promoters—were inserted into yeast on a tiny circular DNA plasmid. The researchers used the yeast cells to transplant the Cas9 gene into the Cas9 proteins, which cut the yeast DNA at specific points. Yeast repair enzymes were then spliced in the four genes and promoters.

Brewers need at least 50 pints of water to grow the hops needed for each pint of beer. They also need fertilizer and energy to transport the crop, making cultivating hops for beer an expensive process.

Hops’ flavorful components, or essential oils, are also highly variable from year to year and plot to plot, meaning a standardized yeast could yield a uniformity of flavor.

This process could be avoided by using yeast to make a hop-forward beer.

“My hope is that if we can use the technology to make great beer that is produced with a more sustainable process, people will embrace that,” Charles Denby, a former UC Berkeley postdoctoral fellow, said in a statement.

To test this, the researchers asked Charles Bamforth, a malting and brewing authority at UC Davis, to brew a beer from three of the most promising strains, using hops only in the initial stage of the brewing.

They then presented the lab-created beer and a control version of the beer that was made using traditional processes to 27 employees of Lagunitas Brewing Company. In double-blind taste tests, the tasters said the beer made from engineered strains was more hoppy than the control beer.

Denby started Berkeley Brewing Science with the aim to market hoppy yeasts to brewers, including strains that contain more of the natural hop flavor components. They also hope to create other strains that incorporate novel plant flavors not usually in beer from the canonical ingredients of water, barley, hops and yeast.


Filed Under: Genomics/Proteomics

 

Related Articles Read More >

Spatial biology: Transforming our understanding of cellular environments
DNA double helix transforming into bar graphs, blue and gold, crisp focus on each strand, scientific finance theme --ar 5:4 --personalize 3kebfev --v 6.1 Job ID: f40101e1-2e2f-4f40-8d57-2144add82b53
Biotech in 2025: Precision medicine, smarter investments, and more emphasis on RWD in clinical trials
DNA helix 3D illustration. Mutations under microscope. Decoding genome. Virtual modeling of chemical processes. Hi-tech in medicine
Genomics in 2025: How $500 whole genome sequencing could democratize genomic data
A media release and Scientific Report image of Elizabeth Kellogg. - Camera Settings: ILCE-9M2, 12mm, ISO 1000, 1/80, f/3.2, Fri, 04-19-2024 at 10:10. v.12.01.23
St. Jude pioneers gene editing and structural biology to advance pediatric research
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE